Delivery Mode and Efficacy of BMP-2 in Association with Implants

Share/Save/Bookmark

Liu, Y. and Huse, R.O. and Groot, K. de and Buser, D. and Hunziker, E.B. (2007) Delivery Mode and Efficacy of BMP-2 in Association with Implants. Journal of Dental Research, 86 (1). pp. 84-89. ISSN 0022-0345

[img] PDF
Restricted to UT campus only
: Request a copy
537kB
Abstract:Bone healing may be improved in implant patients by the administration of osteogenic agents, such as bone morphogenetic protein 2 (BMP-2). But the efficacy of BMP-2 depends upon its mode of application. We hypothesized that BMP-2 is capable of a higher osteogenic efficacy when delivered physiologically, viz., when incorporated into a calcium-phosphate carrier that mimics mineralized bone matrix, than when administered via simple pharmacological modes, such as by adsorption onto a carrier surface. Using an ectopic rat model, we compared the osteoinductive efficacies of calcium-phosphate implant-coatings bearing either incorporated, adsorbed, or incorporated and adsorbed BMP-2. When adsorbed directly onto the naked implant surface, BMP-2 was not osteogenic. When adsorbed onto a calcium-phosphate coating, it was osteoinductive, but not highly efficacious. When BMP-2 was incorporated into calcium-phosphate coatings, it was a potent bone-inducer, whose efficacy was compromised, not potentiated, by the additional deposition of an adsorbed pool.
Item Type:Article
Copyright:© 2007 Sage
Link to this item:http://purl.utwente.nl/publications/68599
Official URL:http://dx.doi.org/10.1177/154405910708600114
Export this item as:BibTeX
EndNote
HTML Citation
Reference Manager

 

Repository Staff Only: item control page

Metis ID: 246236